LUCENTIS
NDC 50242-082, RANIBIZUMAB, injection, solution, from Genentech, Inc..
- Product NDC
- 50242-082
- Status
- Listed
- Labeler
- Genentech, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125156
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50242-082 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RANIBIZUMAB6 mg/mL
Pharmacologic classes
Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50242-082-03 | 50242008203 | 1 SYRINGE, GLASS in 1 CARTON (50242-082-03) / .05 mL in 1 SYRINGE, GLASS |
| 50242-082-88 | 50242008288 | 1 SYRINGE, GLASS in 1 CARTON (50242-082-88) / .05 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/de4e66cc-ca05-4dc9-8262-e00e9b41c36dMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=50242-082
Use it
Look up 50242-082 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50242-082 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50242-082. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.